ABSTRACT -Sodium valproate (VPA) is a major antiepileptic drug that is widely used for the treatment of epilepsy as well as other neuropsychiatric diseases. The present study was conducted to evaluate the ovarian toxicity of VPA using cultured rat ovarian follicles. Secondary follicles were isolated from the ovaries of 14-day-old female rats and cultured for 48 hr with VPA (0, 0.2, 1.0, and 5.0 mM). At 0, 24, and 48 hr of VPA treatment, follicular diameters were measured. After the culture, viability of follicles and expression of aromatase in the follicles were assessed, and progesterone, androstenedione, testosterone, and estradiol levels in culture media were measured. At all concentrations of VPA, follicular development was suppressed, and androstenedione, testosterone, estradiol, and combined levels of all steroid hormones tended to decrease in association with suppression of aromatase expression in granulosa cells. Additionally, the suppression of follicular development was associated with decreased viability of follicles and an increased progesterone level at 5.0 mM of VPA. The decrease in the combined levels of all steroid hormones implies that VPA suppresses the synthetic pathway from cholesterol to estradiol including de novo synthesis of cholesterol. In conclusion, VPA induces ovarian toxicity via suppression of development and abnormal steroid hormone synthesis in cultured rat ovarian follicles.
INTRODUCTION
Sodium valproate (VPA) is a major antiepileptic drug, and has been widely used for not only the treatment of epilepsy but also that of other neuropsychiatric diseases such as bipolar disorders, migraine, and generalized mood disorders (Bowden, 2003; Owens and Nemeroff, 2003; Peterson and Naunton, 2005) . Despite the efficacy of VPA in the treatment of various neurological disorders, its long-term treatment has been known to induce many characteristics of polycystic ovary syndrome (PCOS), including menstrual disorders, hyperandrogenism, polycystic ovaries, and obesity (Isojarvi et al., 1993 (Isojarvi et al., , 2005 . On the other hand, it has also been reported that underlying epileptic disorders themselves are related to reproductive endocrine dysfunction (Morrell and Montouris, 2004; Herzog, 2008) .
In experimental studies using non-epileptic female rats, long-term treatment with VPA reduced estradiol levels, accompanied with inducing an imbalance in testosterone-estradiol ratio (Sveberg Roste et al., 2002) and reduction of testosterone levels (Tauboll et al., 1999) . These findings imply that VPA causes reproductive endocrine dysfunction independently of epileptic activity itself. Additionally, there are some reports on VPA regarding reproductive endocrine dysfunction using cultured theca cells from rat ovaries (Fisseha et al., 2010) and granulosa cells from human and porcine ovaries (Tauboll et al., 2003 (Tauboll et al., , 2006 . Although these in vitro experiments provide new insights to reproductive endocrine dysfunction induced by VPA, the results are not directly applicable to evaluation of the effects of VPA on the fol-licular organization and entire synthetic pathway of steroid hormones, because the culture systems of these isolated cells do not have complete components of ovarian follicles.
Culture of ovarian follicles enables assessment of the potential ovarian toxicity of chemicals on the follicular organization and entire synthetic pathway of steroid hormones, since the follicles are composed of theca cells, granulosa cells, and oocytes. We have evaluated the direct effects of mono-(2-ethylhexyl) phthalate (MEHP) on rat ovarian follicles cultured for the treatment period of 48 hr, and found its ovarian toxicity via suppression of follicular development and abnormal steroid hormone synthesis (Inada et al., 2012) . The present study was conducted to evaluate the effects of VPA on the follicular development and steroid hormone synthesis using cultured rat ovarian follicles.
MATERIALS AND METHODS

Reagents
VPA was purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Alpha-minimum essential medium (α-MEM) and Leibovitz's L-15 (L-15) medium were purchased from DS Pharma Biomedical Co., Ltd. (Osaka, Japan). Collagenase Type I-A, deoxyribonuclease I (DNase), albumin from bovine serum (BSA), 8-bromoguanosine 3′,5′-cyclic monophosphate sodium salt monohydrate (8-Br-cGMP), FSH from human pituitary (hFSH), insulin-transferrin-selenium +1 liquid media supplement (ITS), and penicillin-streptomycin solution were purchased from Sigma-Aldrich, Inc. (Tokyo, Japan).
Animals
All experimental procedures were approved by the Institutional Animal Care and Use Committee of Dainippon Sumitomo Pharma Co., Ltd. (Osaka, Japan). Fourteen-day-old female Sprague-Dawley rats (Crl:CD(SD) rats) were obtained from Charles River Laboratories Japan, Inc. (Kanagawa, Japan). The rats were used for the experiment immediately after receipt.
Isolation and culture of ovarian follicles
Ovarian follicles were isolated and cultured using techniques reported previously (McGee et al., 1997; Rose et al., 1999; Wang et al., 2003; Fowler and Spears, 2004) . In the present study, immature 14-day-old rats were selected because of the high number of secondary follicles, minimal cell apoptosis and expression of FSH receptors in the ovaries, which are observed at the age (McGee and Hsueh, 2000) . The female rats were euthanized by decapitation and the ovaries were collected aseptically into sterilized phosphate buffered saline (PBS). The ovaries were incubated with shaking at 37°C for 30 min in α-MEM supplemented with 4 mg/ml collagenase and 0.2 unit/ml DNase. After incubation, the ovaries were transferred into L-15 medium supplemented with 3 mg/ml BSA, and secondary follicles (< 180 μm in diameter) were manually dissected using 25-gauge needles in the medium. Ovarian follicles with normal morphological appearance were individually pre-cultured in Millicell-CM culture plate inserts (PICM 01250; Nihon Millipore K.K., Tokyo, Japan) with 300 μl α-MEM supplemented with 1 mg/ml BSA, 5 mM 8-Br-cGMP, 100 ng/ml hFSH, 1% (v/v) ITS and 1% (v/v) penicillin-streptomycin solution at 37°C in a humidified atmosphere of 5% CO 2 and 95% air for 24 hr. After pre-culture, intact follicles were selected, the follicular diameters were measured under an inverted microscope (original magnification, 400 ×) using an objective micrometer (OB-M, 1/100; Olympus Corporation, Tokyo, Japan) precalibrated for microscope digital camera system (DP12; Olympus Corporation), and they were allocated to four groups. After allocation, 180 μl of used medium was exchanged for fresh medium supplemented with VPA (final concentrations: 0 mM for control group; and 0.2, 1.0, and 5.0 mM), and the follicles were cultured under the same condition as described above for additional 48 hr (the VPA treatment period). After 24 hr of VPA treatment, medium exchanges were conducted. The concentrations of VPA were based on the therapeutic serum levels of VPA. The concentration of 1.0 mM is equivalent to 166 μg/ml, which is close to the maximum therapeutic level in human.
Follicular development and viability of ovarian follicles
Follicular diameters were measured at 0, 24, and 48 hr of the VPA treatment period using the objective micrometer as described above. After 48 hr of VPA treatment, cultured follicles were stained with 0.08% (w/v) trypan blue (Gibco 0.4% (w/v) Trypan Blue Stain; Life Technologies Japan Ltd., Tokyo, Japan) at room temperature for 5 min (Demirci et al., 2001) . They were washed in PBS, and the trypan blue-positive cells were counted using an inverted microscope (original magnification, 400 ×). Ovarian follicles with less than 10 trypan blue-positive cells were classified as normal follicles, and those with 10 or more trypan blue-positive cells were classified as damaged follicles (Myllymaki et al., 2005) .
Steroid hormone assay
After 48 hr of VPA treatment, the medium was individually sampled and stored at -80ºC. Progesterone, testosterone, and estradiol levels in the medium were measured with EIA kits (Progesterone EIA Kit, Testosterone EIA Kit, and Estradiol EIA Kit, respectively; Cayman Chemical Company, Ann Arbor, MI, USA). An androstenedione level in the medium was measured with an ELISA kit (Androstenedione ELISA Kit; IBL Hamburg GmbH, Hamburg, Germany). Progesterone, androstenedione, testosterone, and estradiol levels in each medium were combined to evaluate the effects of VPA on synthetic pathway from cholesterol to progesterone, including de novo synthesis of cholesterol. Progesterone/androstenedione, androstenedione/testosterone, and testosterone/estradiol ratios were calculated to evaluate the effects of VPA on the respective conversions.
Aromatase detection by immunohistochemistry
At 48 hr of the VPA treatment period, the follicles were fixed and preserved in 10% (w/v) neutral buffered formalin, and then stained with hematoxylin, wrapped in agar, further embedded in paraffin, and sectioned at 2 μm thickness. The tissue slides were heated in 10 mM citrate buffer (pH 6.0) (Dako REAL TM target retrieval solution; Dako Japan Inc., Tokyo, Japan) in a pressure cooker for 10 min. Endogenous peroxidase activity was blocked with 3% (w/v) hydrogen peroxide for 5 min at room temperature. Nonspecific binding of antibodies was blocked with ELISA/Western blotting blocking agent (Block Ace Powder; DS Pharma Biomedical Co., Ltd., Osaka, Japan) for 15 min at room temperature. Thereafter, the tissue slides were incubated for 60 min at room temperature with a 1:100 dilution of mouse anti-human cytochrome P450 aromatase (AbD Serotec, Kidlington, UK) in antibody diluent (Dako Antibody Diluent; Dako Japan Inc., Tokyo, Japan). The slides were incubated for 30 min at room temperature with universal immuno-peroxidase polymer for rat tissue sections (Histofine ® Simple Stain Rat MAX PO (MULTI); Nichirei Biosciences Inc., Tokyo, Japan). The slides were visualized with 0.02% (w/v) 3,3′-diaminobenzidine tetrahydrochloride (Nacalai Tesque, Inc., Kyoto, Japan) and mounted with malinol (Muto Pure Chemicals Co., Ltd., Tokyo, Japan).
Statistical analyses
Data obtained for follicular development and steroid hormone assays are presented as means ± S.D. Data for the follicular development were analyzed using Tukey's test for multiple comparisons. Data for the steroid hormone assays were analyzed using Dunnett's and Steel's tests in the homogeneous and heterogeneous cases, respectively, after testing homogeneity of variance in the data by Bartlett's test. Differences were considered statistically significant for p < 0.05.
RESULTS
Effects of VPA on follicular development
At the initiation of VPA treatment, the follicular diameters were 187.2 ± 20.6, 185.2 ± 15.0, 186.0 ± 12.4, and 185.5 ± 10.9 μm (n = 6 per group) in the control and VPA 0.2, 1.0, and 5.0 mM groups, respectively (Fig. 1) . In the control group, the follicles developed time-dependently during the treatment period. However, VPA inhibited the follicular development in a concentration-dependent manner after 48 hr of treatment.
Effects of VPA on viability of ovarian follicles
Trypan blue-positive cells were detected in granulosa layers, but not in theca layers. All the ovarian follicles in the control and VPA 0.2 and 1.0 mM groups were classified as normal follicles (Table 1 ). In the VPA 5.0 mM group, however, all the follicles were classified as damaged follicles.
Effects of VPA on steroid hormone synthesis
Progesterone levels in the media significantly increased in the VPA 5.0 mM group (p < 0.05) compared to the con- trol group (Fig. 2A) . Androstenedione, testosterone, and estradiol levels decreased or tended to decrease in all the VPA groups in a concentration-dependent manner (Figs. 2B-D). Combined steroid hormone levels calculated by summing the levels of progesterone, androstenedione, testosterone, and estradiol were significantly lower in the VPA 0.2, 1.0, and 5.0 mM groups (p < 0.05, 0.01, and 0.05, respectively) than in the control group (Fig. 2E) .
To evaluate the effects of VPA on conversion from progesterone to estradiol, progesterone/androstenedione, androstenedione/testosterone, and testosterone/estradiol ratios were calculated ( Table 2 ). The progesterone/androstenedione and androstenedione/testosterone ratios significantly increased in the VPA 5.0 mM group (p < 0.05) compared to the control group. The testosterone/estradiol ratio tended to increase in the VPA 0.2, 1.0, and 5.0 mM groups (approximately 3.1-, 3.2-, and 3.0-fold higher than in the control group, respectively).
Effects of VPA on aromatase expression
In the control group, positive immunostaining for aromatase was observed in granulosa cell layers, but not in theca cell layers (Fig. 3A) . However, positive immunostaining was observed in neither theca cell layers nor granulosa cell layers in the VPA 0.2, 1.0, and 5.0 mM groups (Figs. 3B-D) .
DISCUSSION
In the present study, VPA at all concentrations decreased the combined steroid hormone levels of progesterone, androstenedione, testosterone, and estradiol. This change implies that VPA suppressed the synthetic pathway from cholesterol to progesterone, including de novo synthesis of cholesterol, in the cultured rat ovarian follicles. VPA has been reported to down-regulate the expression of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (HMGCR), steroidogenic acute regulatory protein (StAR), P450 side-chain cleavage (P450scc, CYP11a), and 3β-hydroxysteroid dehydrogenase (3β-HSD) genes in human adrenocarcinoma H295R cells (Gustavsen et al., 2009 ). The cells have been reported to express all the key enzymes for steroidogenesis (Gazdar et al., 1990; Rainey et al., 1994) and are widely used for in vitro steroidogenesis assay (Sanderson et al., 2002; Hecker and Giesy, 2008) . HMGCR is a ratelimiting enzyme in cholesterol synthesis (Yeaman, 2004) , and StAR mediates transfer of cholesterol from the out- Rat ovarian follicles were cultured with VPA (0, 0.2, 1.0, and 5.0 mM), and stained with trypan blue at 48 hr of the VPA treatment period. Follicles with less than 10 trypan blue-positive cells were classified into normal follicles, and those with 10 or more trypan blue-positive cells into damaged follicles. Rat ovarian follicles were cultured with VPA (0, 0.2, 1.0, and 5.0 mM). Individual progesterone, androstenedione, testosterone and estradiol levels in the media were measured at 48 hr of the VPA treatment period, and progesterone/androstenedione (PROG/AND), androstenedione/testosterone (AND/TEST) and testosterone/estradiol (TEST/EST) ratios were calculated. The data are presented as means ± S.D. # ; Significantly different from control, p < 0.05 (Steel's test).
er to the inner mitochondrial membrane (Stocco, 2001) . P450scc is localized in the inner mitochondrial membrane and converts cholesterol to the first steroid, pregnenolone, in the mitochondria (Farkash et al., 1986) , and then the pregnenolone exits the mitochondria and is converted to the first active steroid, progesterone, by 3β-HSD in the ovaries (Eimerl and Orly, 2002) . In the assay of each steroid hormone, androstenedione, testosterone, and estradiol levels decreased or tended to decrease at all concentrations of VPA in a concentra- tion-dependent manner. As described above, the decrease or tendency toward a decrease in these steroid hormones is considered to be mainly attributable to the suppression of the synthetic pathway from cholesterol to progesterone by VPA, but not attributable to the decreased viability of cultured rat ovarian follicles because the changes of these steroid hormones at 0.2 and 1.0 mM were not accompanied with follicular damage examined by trypan blue staining. The decrease or tendency toward a decrease in the estradiol level at all concentrations of VPA was accompanied with a tendency toward an increase in the testosterone/estradiol ratio. The tendency toward an increase in the testosterone/estradiol ratio suggests that VPA inhibited the conversion from testosterone to estradiol. VPA has been reported to inhibit the conversion from testosterone to estradiol in female rats (Sveberg Roste et al., 2002) , primary cultured porcine ovarian follicular cells (Tauboll et al., 2003) , and H295R cells (von Krogh et al., 2010) . The conversion of testosterone to estradiol is mainly catalyzed by aromatase in the ovarian follicles, and an aromatase inhibitor, anastrozole, induces ovarian toxicity including follicular cyst and abnormal estrous cycle (Shirai et al., 2009) . The expression of CYP19, which encodes aromatase, is down-regulated by VPA in H295R cells (von Krogh et al., 2010) . In the present study, aromatase was expressed in the granulosa cells of cultured follicles in the control group, and the expression was suppressed at all concentrations of VPA. These findings imply that VPA inhibits the conversion of testosterone to estradiol by suppression of aromatase expression in granulosa cells of cultured follicles. Moreover, the decreases in the testosterone and estradiol synthesis, and the tendency toward an increase in the testosterone/estradiol ratio, which were observed in the present study, are consistent with the results of in vivo studies of long-term treatment (90 days) with VPA using female rats (Tauboll et al., 1999; Sveberg Roste et al., 2002) . At 5.0 mM of VPA, the progesterone level remarkably increased, in addition to the decreases in androstenedione, testosterone, and estradiol levels, and the increase was accompanied with increases in the progesterone/androstenedione and androstenedione/testosterone ratios. The Vol. 37 No. 3 increases in the progesterone/androstenedione and androstenedione/testosterone ratios suggest that VPA inhibited the conversion from progesterone to androstenedione and from androstenedione to testosterone, respectively. Conversion of progesterone to androstenedione is catalyzed by 17α-hydroxylase (17α-OHase) and 17, 20-lyase (lyase), which are encoded by CYP17, and VPA has been reported to down-regulate the expression of CYP17 at 1.5 mM in H295R cells (Gustavsen et al., 2009 ). Therefore, it is considered that the remarkable increase in the progesterone level and the decrease in the androstenedione level at 5.0 mM are partly attributable to the inhibitory effects of VPA on 17α-OHase and lyase activity. At 5.0 mM, the combined steroid hormone level was decreased, but showed a recovery tendency compared at 1.0 mM. The recovery implies that VPA activates a part of synthetic pathway from cholesterol to progesterone, including de novo synthesis of cholesterol, in the cultured follicles, and the activation might be related to the increase in progesterone level, at 5.0 mM. Additionally, the conversion of androstenedione to testosterone has been known to be catalyzed by 17β-hydroxysteroid dehydrogenase (17β-HSD). VPA has been reported to reduce expression of 17β-HSD mRNA at 500 μg/ml (equivalent to 3.0 mM) in primarily cultured rat theca-interstitial cells (Fisseha et al., 2010) . Therefore, it is considered that the decrease in the testosterone level accompanied with the increase in the androstenedione/testosterone ratio at 5.0 mM is related to the inhibitory effects of VPA on 17β-HSD activity. VPA suppressed follicular development in a concentration-dependent manner, and the suppression at 5.0 mM was accompanied with decreased viability of cultured rat ovarian follicles. One possible mechanism underlying the suppression of follicular development might be related to the decrease in androstenedione and testosterone synthesis, because it has been reported that androgens stimulate the growth and development of mouse and bovine ovarian follicles through androgen receptors in the early stages of folliculogenesis (Murray et al., 1998; Yang and Fortune, 2006) . In the present study, VPA at all concentrations reduced androstenedione and testosterone synthesis. The decreased viability of ovarian follicles observed at 5.0 mM might be related to the decrease in estradiol synthesis, because this change was accompanied with an extreme decrease in an estradiol level. It has been reported that apoptosis of granulosa cells is inhibited by estrogens (Kaipia and Hsueh, 1997; Quirk et al., 2006) , and that incidence of apoptosis of granulosa cells is related to decreased estradiol synthesis in bovine follicles (Valdez et al., 2005) . Additionally, long-term treatment (90 days) with VPA has been reported to induce apoptosis of granulosa cells in rat ovaries (Cansu et al., 2008) . Therefore, it is considered that the suppression of follicular development is related to the inhibitory effects of VPA on steroid hormone synthesis, and, especially, the decreased viability of cultured rat ovarian follicles at 5.0 mM.
In conclusion, VPA induced ovarian toxicity via suppression of follicular development accompanied with decreased viability of ovarian follicles and abnormal steroid hormone synthesis including decreased estradiol synthesis related to suppression of aromatase expression in the cultured rat ovarian follicles. These results show that we can evaluate the direct effects of VPA on the ovarian morphology, including follicular development, and on the overall synthetic pathway of steroid hormones, without respect to the feedback system in the hypothalamicpituitary-ovarian axis, in a short time with a small amount of chemical using this method. Additionally, we reported ovarian toxicity of MEHP using a similar culture system of rat ovarian follicles in our previous study (Inada et al., 2012) . Taken together, the method using cultured rat ovarian follicles is considered useful to evaluate the potential ovarian toxicity of medicinal compounds and chemicals including medicinal products.
